← Back to Search

Behavioral Intervention

Dissonance-Based Program for Obesity Prevention (PHPhase2 Trial)

N/A

Waitlist Available

Led By Eric Stice, PhD

Research Sponsored by Oregon Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 17 and 20 years old

Be younger than 65 years old

Must not have

Current diagnosis of anorexia nervosa, bulimia nervosa or binge eating disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, posttest (approximately 8 weeks later), 6-month follow-up (approximately 34 weeks after baseline), 12-month follow-up (approximately 60 weeks after baseline)

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a program to reduce unhealthy weight gain, & prevent eating disorder symptoms, in 17-20 year olds with weight concerns. Results will inform broader implementation.

Who is the study for?

This trial is for 17-20 year olds who are concerned about their weight, believe they can improve their diet and exercise habits, and have a BMI between 20 to 30. It's not for those with anorexia, bulimia, binge eating disorder or past participants in Project Health studies.

What is being tested?

The study tests if a dissonance-based obesity prevention program combined with food response training beats an educational video at preventing weight gain. Participants will be randomly placed into groups and followed up over a year.

What are the potential side effects?

Since this trial involves behavioral interventions rather than medication, typical drug side effects aren't expected. However, participants may experience psychological discomfort from the discussions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 17 and 20 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with an eating disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, posttest (approximately 8 weeks after baseline), 6-month follow-up (approximately 34 weeks after baseline), 12-month follow-up (approximately 60 weeks after baseline)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, posttest (approximately 8 weeks after baseline), 6-month follow-up (approximately 34 weeks after baseline), 12-month follow-up (approximately 60 weeks after baseline)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, posttest (approximately 8 weeks after baseline), 6-month follow-up (approximately 34 weeks after baseline), 12-month follow-up (approximately 60 weeks after baseline) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Body Fat

Secondary study objectives

Eating Disorder Symptoms

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Male Group, Food Response TrainingExperimental Treatment2 Interventions

Participants in this arm will be assigned to receive Project Health in male-only groups and will complete the food-focused response and attention training intervention.

Group II: Female Group, Food Response TrainingExperimental Treatment2 Interventions

Participants in this arm will be assigned to receive Project Health in female-only groups and will complete the food-focused response and attention training intervention.

Group III: Educational Video controlActive Control1 Intervention

Participants in this arm will be assigned to watch a four-part documentary "The Weight of the Nation" from their home.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Project Health

2023

N/A

~430

0 / 2Eligibility criteria met